Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

Common Stock · CUSIP: 04351P101

Event date: 2025-12-31

Filing-level shares
5,185,696
Percent of class
8.48%
  • Westfield Capital Management Company, L.P.

    Shares: 5,185,696 · Class: 8.48%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001177719-26-000008
Form type
SCHEDULE 13G/A
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
Feb 11, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub